SAB Biotherapeutics, Inc. (SABS) — 分析师展望 / 分析师共识目标价为. 基于 6 位分析师评级, 共识为 看涨 — 5 买入, 1 持有.
分析师共识目标价为 $7.00, 上涨空间为 81.3% 相对于当前价格 $3.86.
分析师预估 每股收益(EPS)为 $-3.68 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-3.68 vs 预期 $-3.68 (超预期 +0%). 2025: 实际 $0.22 vs 预期 $-0.41 (超预期 +153.4%). 分析师准确度: 0%.
SABS 股票 — 12个月价格预测
$7.00
▲ +81.35% 上涨空间
平均目标价
Based on 6 Wall Street analysts offering 12-month price targets for SAB Biotherapeutics, Inc., the price target is $7.00.
平均目标价相对最新价格 $3.86 变动 +81.35%。
SABS 分析师评级
Buy
基于过去3个月内 6 位分析师对 SAB Biotherapeutics, Inc. 的评级
EPS 预测 — SABS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$3.68
vs Est –$3.68
▼ 0.0% off
2025
Actual $0.22
vs Est –$0.41
▲ 287.1% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
营收预测 — SABS
100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.001B
vs Est $0.001B
▼ 0.1% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
